Phoenix Biotech Acquisition Corp. (CERO)
Market Closed
17 Jan, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 34
-0.15
-6.02%
$
36.47M Market Cap
- P/E Ratio
0% Div Yield
313,200 Volume
- Eps
$ 2.49
Previous Close Day Range
2.21 2.51
Year Range
0.05 12.38
Summary
CERO closed Friday lower at $2.34, a decrease of 6.02% from Thursday's close, completing a monthly decrease of -62.26% or $3.86. Over the past 12 months, CERO stock lost -62.26%.
CERO is not paying dividends to its shareholders.
Phoenix Biotech Acquisition Corp. has completed 1 stock splits, with the recent split occurring on Jan 08, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).
Want to track CERO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CERO Chart
FAQ
What Is the Phoenix Biotech Acquisition Corp.(CERO) Stock Price Today?
The CERO stock price today is $2.34.
What Stock Exchange Does Phoenix Biotech Acquisition Corp. Trade On?
Phoenix Biotech Acquisition Corp. is listed and trades on the NASDAQ (NMS).
What Is the Stock Symbol for Phoenix Biotech Acquisition Corp.?
The stock symbol for Phoenix Biotech Acquisition Corp. is "CERO".
Does Phoenix Biotech Acquisition Corp. Pay Dividends? What's The Current Dividend Yield?
CERO is not paying dividends to its shareholders.
What Is the Phoenix Biotech Acquisition Corp. Market Cap?
As of today, Phoenix Biotech Acquisition Corp. market cap is 36.47M.
Did Phoenix Biotech Acquisition Corp. had any splits?
Phoenix Biotech Acquisition Corp. had 1 splits and the recent split was on Jan 08, 2025.
Phoenix Biotech Acquisition Corp. Profile
| Shell Companies Industry | Financial Services Sector | Mr. Christopher B. Ehrlich M.B.A. CEO | NASDAQ (NMS) Exchange | - ISIN |
| United States Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
Contact Information
Address: 2201 Broadway
Phone: 215 731 9450
2025 © Marketlog. All Rights Reserved.
